| Literature DB >> 32182933 |
Liyuan Qiang1, Zeinab H Arabeyyat2, Qi Xin1, Vesselin N Paunov3, Imogen J F Dale4, Richard I Lloyd Mills4, Jeanette M Rotchell4, Jinping Cheng1,5.
Abstract
Silver nanoparticles (AgNPs) are widely used in commercial applications as antimicrobial agents, but there have recently been increasing concerns raised about their possible environmental and health impacts. In this study, zebrafish embryos were exposed to two sizes of AgNP, 4 and 10 nm, through a continuous exposure from 4 to 96 h post-fertilisation (hpf), to study their uptake, impact and molecular defense responses. Results showed that zebrafish embryos were significantly impacted by 72 hpf when continuously exposed to 4 nm AgNPs. At concentrations above 0.963 mg/L, significant in vivo uptake and delayed yolk sac absorption was evident; at 1.925 mg/L, significantly reduced body length was recorded compared to control embryos. Additionally, 4 nm AgNP treatment at the same concentration resulted in significantly upregulated hypoxia inducible factor 4 (HIF4) and peroxisomal membrane protein 2 (Pxmp2) mRNA expression in exposed embryos 96 hpf. In contrast, no significant differences in terms of larvae body length, yolk sac absorption or gene expression levels were observed following exposure to 10 nm AgNPs. These results demonstrated that S4 AgNPs are available for uptake, inducing developmental (measured as body length and yolk sac area) and transcriptional (specifically HIF4 and Pxmp2) perturbations in developing embryos. This study suggests the importance of particle size as one possible factor in determining the developmental toxicity of AgNPs in fish embryos.Entities:
Keywords: continuous exposure; developmental toxicity; embryos (D. rerio); molecular response; silver nanoparticles; uptake
Mesh:
Substances:
Year: 2020 PMID: 32182933 PMCID: PMC7084859 DOI: 10.3390/ijms21051876
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923
Figure 1Transmission electron microscopy images of S4 (A) and S10 (B) silver nanoparticles (AgNPs). Histograms of the size distribution for S4 (C) and S10 (D).
Figure 2Representative phenotypes of zebrafish embryos upon exposure to AgNP concentration of (B) 1.925 mg/L, compared with the control (A) at 72 hpf. Scale bar = 500 μm.
Figure 3Percentage change of (A) body length and (B) yolk sac area of zebrafish embryos following exposure to AgNPs (at 0.481, 0.963, 1.925 mg/L) compared with the control (without AgNPs) at 72 hpf. Values represent mean ± standard error. Results have been normalised on control (0 µg/L). The body length of control embryos was (3.618 ± 0.047) mm (S4) and (3.603± 0.009) mm (S10), and the yolk sac area of control embryos was (0.328 ± 0.014) mm2 (S4) and (0.333 ± 0.011) mm2 (S10). * significant difference between samples and the control groups using one-way ANOVA. * p < 0.05. n = 4.
Figure 4Silver content in wet weight of fish embryos exposed to AgNPs from 4 to 96 hpf. Values represent mean ± standard error. * significant difference between samples and the control groups using one-way ANOVA. * p < 0.05. n = 4.
Figure 5qPCR mRNA transcript levels for (A) SOD2, (B) CAT, (C) HIF4, (D) Pxmp2 and (E) Muc genes in zebrafish embryos at 96 hpf following exposure to AgNO3 (18 µg/L Ag+), S4 AgNPs (1.925 mg/L), and S10 AgNPs (1.925 mg/L). Values represent mean ± standard error. * significant difference between samples and the control groups using either two-sample t-test or Mann–Whitney test. * p < 0.05. n = 4.
A summary of the observed toxicity impacts of AgNPs and silver ions reported in the literature.
| Organism | Source | Exposure Period | NP Sizes | Exposure Concentration | Ag Uptake of Negative Control | Ag Uptake | Biological Effects | References |
|---|---|---|---|---|---|---|---|---|
|
| AgNPs | 0–4 days | 3–8 nm | 0.1 and 0.125 mg/L | — | — | Induced delayed hatching and formation of oedema. | [ |
| AgNO3 | — | 0.04 and 0.08 mg/L | Ag+ decreased absorption of yolk sac and resulted in pericardial oedema. | |||||
|
| AgNPs | 6–120 hpf | 10 nm | 1.7 and 5.1 mg/L | — | — | AgNPs induced slowed swim bladder inflation. | [ |
| AgNO3 | — | 0.51, 1.7 and 5.1 mg/L | Ag+ slowed swim bladder inflation. | |||||
|
| AgNPs | 4–24 and | 10 nm | 0.005 mg/L | — | — | AgNPs altered gene expression associated with oxidative phosphorylation and protein synthesis. | [ |
| AgNO3 | 4–24 hpf | — | 0.00025 mg/L | Ag+ altered oxidative phosphorylation and protein synthesis gene expression. | ||||
|
| AgNPs | 0–4 days | 20 nm | 1 mg/L | Gill and intestine: | Gill: 5.11 μg/adult | AgNPs decreased ATPase enzyme activity. | [ |
| AgNO3 | — | Gill: 1.66 μg/adult | Ag+ decreased ATPase enzyme activity. | |||||
|
| AgNPs | 4–96 hpf | 10 nm | 1.925 mg/L | Head and trunk: | Head: 0.03 ng/embryo | AgNPs induced small head, small eye and cardiac defects, and altered the gene expression of neural development-related, metal-sensitive metallothioneins, and detoxification. | [ |
|
| AgNPs | 4–96 hpf | 4 nm | 1.925 mg/L | Whole body tissue: | Whole body tissue: 21.47 ng/g | AgNPs decreased body length, delayed yolk sac absorption, and altered oxidative stress and channel-forming protein gene expression. | This study |
|
| AgNPs | 0–48 h | 26.6 ± 8.8 nm | 1 mg/L | Carcass: 0.02 ng/g | Carcass: 0.47 ng/g | AgNPs altered signal transducer activity, enzyme activity and membrane function gene expression. | [ |
|
| AgNO3 | 1–24, 1–48 | — | 0.02 mg/L | — | — | Ag+ altered detoxifying processes and oxidative stress gene expression. | [ |
|
| AgNO3 | hatch | — | 0.1 mg/L | — | — | Ag+ accelerated hatching and decreased absorption of yolk sac. | [ |
Primer pairs used for the isolation of candidate and reference genes from zebrafish embryos.
| Targeted Transcript | Forward Primer (5′-3′) | Reverse Primer (5′-3′) | Amplicon Size (bp) |
|---|---|---|---|
|
| TAGAGGGACAAGTGGCGTTC | CCTCGTTGATGGGAAACAGT | 195 |
|
| GATGCACCACGAGTCTCTGA | TGATGACCTGAGCGTTGAAG | 158 |
|
| TGGGATCGCAAAACCACTGT | GTTGTGCATCAGGGCAAGTG | 187 |
|
| AGTTACTGGCCTGCGATGAA | CACTGCAGTAAGGCACAACC | 157 |
|
| AGACTGCCACGGAAAAGCTA | CCAGAGGCAGAAGAGCAGTT | 161 |
|
| GCGGATACCAGAGAGAGTCG | ATCTGATGACCCAGCCTCAC | 172 |
|
| AGCGTGACTTTGGCTCATTT | ATGAGACCTGTGGTCCCTTG | 166 |